Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
about
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.Independent factors for prediction of poor outcomes in patients with febrile neutropeniaManagement of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropeniaManagement of febrile neutropenia: ESMO Clinical Practice Guidelines.Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer.Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project.Utility of the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index Score as a Criterion for Nonadmission in Febrile Neutropenic Patients with Solid TumorsSafety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients.Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks?Early discharge and ambulatory care of low-risk patients with neutropenic fever in Australia.Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment.Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.Understanding the risk for infection in patients with neutropenia.A new prognostic model for chemotherapy-induced febrile neutropenia.Developments in the management of febrile neutropenia.Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
P2860
Q33390157-9125CCB3-2633-40F0-84F6-A9239FEB27E5Q34350273-EB791FD5-F8A5-4A4E-9AE8-0F68F8A26E05Q34403621-BCF1F9DE-62CF-42E5-BB24-ADF9CD99A132Q34620670-AB763002-98B6-4DD4-AF7B-1AAB5FE9953AQ34678894-1B097441-18DC-41A1-8A35-69225096EC61Q35078855-F1D2DF2E-BD7A-4C8B-BE54-32F3AF6A6995Q35165579-E9A76625-BEE2-4E59-A8D0-6A1F25204012Q35846480-CD1373B8-3C85-4CBE-A95A-2FC07FECC79BQ36910461-8DFA3FE4-6A17-46A7-BDB8-F7170CDE995BQ37931905-40620E9B-97E4-40AD-AF65-3897B162E244Q37963923-F5CEE813-0F4C-47FC-939C-E8C4396011F7Q38084890-026B2923-6206-44DE-83D7-4FF51AE721F6Q38909993-E9CB53BD-7A20-4F25-9CC9-75AD9B0CC019Q40170349-EE7CD04D-6BD7-4A13-A086-5DBA013403D4Q40240657-EFC9F6CA-8D65-4D63-BFC6-D2EF53258C34Q40240784-307537A8-F4BD-4914-9126-D2B69D08C524Q40248053-AECB473F-55F8-483D-98B9-E71864FA93B1Q40284053-B6CB5DAA-BD37-4469-9766-E2BF11EA13C6Q40335985-FC5C3C3C-219B-42CE-A223-E29BB316F93CQ41110370-9D55A94C-00D9-41ED-A890-07B9ED1BCBA6Q41180338-0B5268BC-BD53-4CB6-BEED-1934D9BB6C2AQ42933847-48925D51-5BC5-4F81-B3EB-F7C8CD810DC5Q52716575-E297F55C-0695-4855-8D09-412B7D26ACB7
P2860
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Management of febrile neutrope ...... in routine clinical practice.
@ast
Management of febrile neutrope ...... in routine clinical practice.
@en
Management of febrile neutrope ...... for Supportive Care in Cancer
@nl
type
label
Management of febrile neutrope ...... in routine clinical practice.
@ast
Management of febrile neutrope ...... in routine clinical practice.
@en
Management of febrile neutrope ...... for Supportive Care in Cancer
@nl
prefLabel
Management of febrile neutrope ...... in routine clinical practice.
@ast
Management of febrile neutrope ...... in routine clinical practice.
@en
Management of febrile neutrope ...... for Supportive Care in Cancer
@nl
P2093
P1476
Management of febrile neutrope ...... in routine clinical practice.
@en
P2093
Allison Hall
Ernest Marshall
Helen Innes
Neeraj Bhalla
Sheow Lei Lim
Su Yin Chan
P2888
P304
P356
10.1007/S00520-007-0334-8
P577
2007-09-25T00:00:00Z